特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
950774

インフルエンザ診断の世界市場:2020年~2024年

Global Influenza Diagnostics Market 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.35円
インフルエンザ診断の世界市場:2020年~2024年
出版日: 2020年07月17日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

インフルエンザ診断市場は2020年から2024年の間に13億2000万米ドル成長すると予測されており、予測期間中のCAGRは10%です。同市場は、POCTの需要の高まり、インフルエンザのパンデミック予防への注目の高まり、インフルエンザの蔓延によって牽引されています。

当レポートでは、インフルエンザ診断市場を調査し、市場概要、市場の成長要因および阻害要因の分析、エンドユーザー別・タイプ別・地域別の市場規模の推移と予測、ベンダー分析、市場機会など、包括的な情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2019年の市場規模
  • 市場の見通し:2019年から2024年の予測

ファイブフォース分析

エンドユーザー別市場セグメンテーション

  • マーケット・セグメント
  • エンドユーザー別比較
  • 病院および診断検査室-市場規模と予測(2019年~2024年)
  • 学術および調査センター-市場規模と予測(2019年~2024年)
  • 在宅ケア-市場規模と予測(2019年~2024年)
  • エンドユーザー別市場機会

タイプ別市場セグメンテーション

  • マーケット・セグメント
  • タイプ別比較
  • ポイントオブケア試験-市場規模と予測(2019年~2024年)
  • 免疫診断-市場規模と予測(2019年~2024年)
  • 分子診断-市場規模と予測(2019年~2024年)
  • タイプ別の市場機会

顧客情勢

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米 -市場規模と予測(2019年~2024年)
  • 欧州-市場規模と予測(2019年~2024年)
  • アジア-市場規模と予測(2019年~2024年)
  • その他の地域-市場規模と予測(2019年~2024年)
  • 主要国
  • 地域の市場機会
  • 市場成長要因
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概観
  • ベンダー情勢
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Quidel Corp.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

付録

目次
Product Code: IRTNTR44375

Technavio has been monitoring the influenza diagnostics market and it is poised to grow by $ 1.32 bn during 2020-2024 progressing at a CAGR of 10% during the forecast period. Our reports on influenza diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing demand for POCT, rising focus on prevention of pandemic influenza, and prevalence of influenza.

The influenza diagnostics market analysis includes end-user segment and geographic landscape.

Technavio's ‘influenza diagnostics market ’ is segmented as below:

By End-user:

  • Hospitals and diagnostic laboratories
  • Academic and research centers
  • Home care

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rising approvals for influenza diagnostic products as one of the prime reasons driving the influenza diagnostics market growth during the next few years. Also, a surge in the number of genetic characterization studies on influenza virus and rising adoption of rapid diagnostic products in physician office laboratories will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our influenza diagnostics market covers the following areas:

  • Influenza diagnostics market sizing
  • Influenza diagnostics market forecast
  • Influenza diagnostics market industry analysis

Technavio's ‘robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading influenza diagnostics market vendors that include Abbott Laboratories, Biocartis Group NV, Bio-Rad Laboratories Inc., Danaher Corp., DiaSorin Spa, GenMark Diagnostics Inc., Meridian Bioscience Inc., Quidel Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Also, the influenza diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End-user
  • Hospitals and diagnostic laboratories - Market size and forecast 2019-2024
  • Academic and research centers - Market size and forecast 2019-2024
  • Home care - Market size and forecast 2019-2024
  • Market opportunity by End-user

Market Segmentation by Type

  • Market segments
  • Comparison by Type
  • Point-of-care testing - Market size and forecast 2019-2024
  • Immunodiagnostics - Market size and forecast 2019-2024
  • Molecular diagnostics - Market size and forecast 2019-2024
  • Market opportunity by Type

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Quidel Corp.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Key Finding 9
  • 9: Parent market
  • 10: Market characteristics
  • 11: Offerings of vendors included in the market definition
  • 12: Market segments
  • 13: Global - Market size and forecast 2019 - 2024 ($ billion)
  • 14: Global market: Year-over-year growth 2019 - 2024 (%)
  • 15: Five forces analysis 2019 & 2024
  • 16: Bargaining power of buyers
  • 17: Bargaining power of suppliers
  • 18: Threat of new entrants
  • 19: Threat of substitutes
  • 20: Threat of rivalry
  • 21: Market condition - Five forces 2019
  • 22: End user - Market share 2019-2024 (%)
  • 23: Comparison by End user
  • 24: Hospitals and diagnostic laboratories - Market size and forecast 2019-2024 ($ billion)
  • 25: Hospitals and diagnostic laboratories - Year-over-year growth 2019-2024 (%)
  • 26: Academic and research centers - Market size and forecast 2019-2024 ($ billion)
  • 27: Academic and research centers - Year-over-year growth 2019-2024 (%)
  • 28: Home care - Market size and forecast 2019-2024 ($ billion)
  • 29: Home care - Year-over-year growth 2019-2024 (%)
  • 30: Market opportunity by End user
  • 31: Type - Market share 2019-2024 (%)
  • 32: Comparison by Type
  • 33: Point-of-care testing - Market size and forecast 2019-2024 ($ billion)
  • 34: Point-of-care testing - Year-over-year growth 2019-2024 (%)
  • 35: Immunodiagnostics - Market size and forecast 2019-2024 ($ billion)
  • 36: Immunodiagnostics - Year-over-year growth 2019-2024 (%)
  • 37: Molecular diagnostics - Market size and forecast 2019-2024 ($ billion)
  • 38: Molecular diagnostics - Year-over-year growth 2019-2024 (%)
  • 39: Market opportunity by Type
  • 40: Customer landscape
  • 41: Market share by geography 2019-2024 (%)
  • 42: Geographic comparison
  • 43: North America - Market size and forecast 2019-2024 ($ billion)
  • 44: North America - Year-over-year growth 2019-2024 (%)
  • 45: Europe - Market size and forecast 2019-2024 ($ billion)
  • 46: Europe - Year-over-year growth 2019-2024 (%)
  • 47: Asia - Market size and forecast 2019-2024 ($ billion)
  • 48: Asia - Year-over-year growth 2019-2024 (%)
  • 49: ROW - Market size and forecast 2019-2024 ($ billion)
  • 50: ROW - Year-over-year growth 2019-2024 (%)
  • 51: Key leading countries
  • 52: Market opportunity by geography ($ billion)
  • 53: Impact of drivers and challenges
  • 54: Vendor landscape
  • 55: Landscape disruption
  • 56: Industry risks
  • 57: Vendors covered
  • 58: Market positioning of vendors
  • 59: Abbott Laboratories - Overview
  • 60: Abbott Laboratories - Business segments
  • 61: Abbott Laboratories - Key offerings
  • 62: Abbott Laboratories - Key customers
  • 63: Abbott Laboratories - Segment focus
  • 64: Biocartis Group NV - Overview
  • 65: Biocartis Group NV - Product and service
  • 66: Biocartis Group NV - Key offerings
  • 67: Biocartis Group NV - Key customers
  • 68: Biocartis Group NV - Segment focus
  • 69: Bio-Rad Laboratories Inc. - Overview
  • 70: Bio-Rad Laboratories Inc. - Business segments
  • 71: Bio-Rad Laboratories Inc. - Key offerings
  • 72: Bio-Rad Laboratories Inc. - Key customers
  • 73: Bio-Rad Laboratories Inc. - Segment focus
  • 74: Danaher Corp. - Overview
  • 75: Danaher Corp. - Business segments
  • 76: Danaher Corp. - Key offerings
  • 77: Danaher Corp. - Key customers
  • 78: Danaher Corp. - Segment focus
  • 79: DiaSorin Spa - Overview
  • 80: DiaSorin Spa - Business segments
  • 81: DiaSorin Spa - Key offerings
  • 82: DiaSorin Spa - Key customers
  • 83: DiaSorin Spa - Segment focus
  • 84: GenMark Diagnostics Inc. - Overview
  • 85: GenMark Diagnostics Inc. - Product and service
  • 86: GenMark Diagnostics Inc. - Key offerings
  • 87: GenMark Diagnostics Inc. - Key customers
  • 88: GenMark Diagnostics Inc. - Segment focus
  • 89: Meridian Bioscience Inc. - Overview
  • 90: Meridian Bioscience Inc. - Business segments
  • 91: Meridian Bioscience Inc. - Key offerings
  • 92: Meridian Bioscience Inc. - Key customers
  • 93: Meridian Bioscience Inc. - Segment focus
  • 94: Quidel Corp. - Overview
  • 95: Quidel Corp. - Business segments
  • 96: Quidel Corp. - Key offerings
  • 97: Quidel Corp. - Key customers
  • 98: Quidel Corp. - Segment focus
  • 99: Siemens Healthineers AG - Overview
  • 100: Siemens Healthineers AG - Business segments
  • 101: Siemens Healthineers AG - Key offerings
  • 102: Siemens Healthineers AG - Key customers
  • 103: Siemens Healthineers AG - Segment focus
  • 104: Thermo Fisher Scientific Inc. - Overview
  • 105: Thermo Fisher Scientific Inc. - Business segments
  • 106: Thermo Fisher Scientific Inc. - Key offerings
  • 107: Thermo Fisher Scientific Inc. - Key customers
  • 108: Thermo Fisher Scientific Inc. - Segment focus
  • 109: Currency conversion rates for US$
  • 110: Research Methodology
  • 111: Validation techniques employed for market sizing
  • 112: Information sources
  • 113: List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.